Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bigvet Biotech is a Chinese animal-health biotechnology company focused on the research, development, manufacturing, and sale of veterinary vaccines, especially foot-and-mouth disease vaccines for livestock. The company is based in Hohhot, Inner Mongolia, and operates Ministry of Agriculture-approved production lines using cell suspension culture technology. Its commercial focus appears to be inactivated foot-and-mouth disease vaccines for pigs, cattle, and sheep used in China's animal disease prevention programs. Bigvet also conducts veterinary biologics R&D and has reported collaborations with Chinese academic institutions on next-generation vaccines and adjuvant technologies. The company operates at commercial scale and participates in government vaccine procurement programs across multiple Chinese provinces.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bigvet Biotech.